Languages
Pages
Legal
Explore all categories to find your favorite topic
Meet Novartis ManagementOverview Disclaimer This presentation contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform
Creating value through responsible business ESG Investor Call September 18 2017 Jürgen Brokatzky-Geiger Global Head Corporate Responsibility Vas Narasimhan Global Head Drug…
Slide 1 Slide 2 Slide 3 Ritalin ® & AD/HD just calming the troublemaker ??? Dr.med.Sven Schellberg Global Communications & Brand Manager Psychiatry NOVARTIS Pharma…
Novartis Ag vs Union Of India & Ors. on 1 April, 2013 Supreme Court of India Supreme Court of India Novartis Ag vs Union Of India & Ors. on 1 April, 2013 Author:…
Innovation: Shaping and Influencing the Analytics / Decision Space The Role of Statistical Methodology in Clinical Research – Shaping and Influencing Decision Making Frank…
Norbert Hollaender Novartis Pharma AG, Oncology Global Development, CH-Basel (email: [email protected]) IQWiG in dialogue, Köln, 27-Jun-2014 Methods to estimate…
1. 2013 17 01 17 D medic CERTIFICATE OF GMP COMPLIANCE (for the Health Authorities of Ecuador) We certify herewith that the company Novartis Pharma Stein AG, Pharmaceutical…
8202019 Novartis Ag vs Union of India Ors. on 1 April%2c 2013 01 160 Supreme Court of India Supreme Court of India Novartis Ag vs Union Of India Ors. on 1 April, 2013 Author:…
Microsoft Word - 526.docNovartis and the United Nations Global Compact Initiative By: Lee A. Tavis William Davidson Working Paper Number 526 December 2002 University of Notre
~ ~ -\ ,~, ~-- In the high court of judicature at madras (special orginal jurisdiction) w.p.no.24759 of 2006 Novartis AG Schwarzwaldalel 215 4058 Basel, and Lichstrasse 35,…
Slide 1Chemical Entity extraction using the chemicalize.org-technology Josef Scheiber Novartis Pharma AG – NITAS/TMS Slide 2 Where the story of this project started...…
The new “Silently pressing” DAC, to address the false perception about “stable” patients INTRODUCTION TO HEART FAILURE © 2015 Novartis Pharma AG, May 2015, GLCM/HTF/0027b…
PRESENTING COMPANIES Crafting a global development strategy 5th Annual Global Clinical Trials SEPTEMBER 10 2014 FAIRMONT COPLEY PLAZA BOSTON MAGC T Organized by WWWTHECONFERENCEFORUMORG…
Slide 1 Sponsored by Novartis Pharma AG 7th Annual International Diovan Symposium Lisbon, 3–5 February 2006 Slide 2 Sponsored by Novartis Pharma AG From the Expert’s…
424B5 1 a2229880z424b5.htm 424B5 Use these links to rapidly review the document TABLE OF CONTENTS TABLE OF CONTENTS Table of Contents Filed Pursuant to Rule 424(b)(5) Registration…
Kisqali® MONALEESA-3 ESMO Data Investor Call Susanne Schaffert President of Novartis Oncology Jeff Legos Head for Oncology Global Development Solid Tumors ai October 1 2019…
ARSN 158 717 072 ANNUAL REPORT FOR THE YEAR ENDED 30 JUNE 2019 CORPORATE DIRECTORY RESPONSIBLE ENTITY Walsh Company Investments Limited Registered Principal Office Level…
Progress in Drug Research Founded by Ernst Jucker Series Editors Prof. Dr. Paul L. Herrling Alex Matter, M.D., Director Novartis International AG Novartis Institute for Tropical…
Thursday, 15 March E-CARGO TRACK CHAIRMAN’S OPENING REMARKS & WELCOME ADDRESS Oliver Neerfeld, Head of Commercial Operations Asia pacific, CHAMP Cargosystems Track…
1. 2015-03-09 1 The Organization of Global Environmental Governance Gunilla Reischl, 9 March, 2015 Introduction • What has the global community done to tackle environmental…